Literature DB >> 16599284

Effect of levetiracetam on truncal tic in neuroacanthocytosis.

Feng-Cheng Lin1, Long-Joy Wei, Pang-Ying Shih.   

Abstract

We report on an uncommon manifestation of neuroacanthocytosis in a 31-year-old woman and the successful use of levetiracetam in the treatment of her neurological symptoms. Truncal tic is one of the major presenting features of this patient. We find that Levetiracetam, a new antiepileptic drug, was effective in eliminating this patient's truncal jerks and motor tic manifestations, such as eyelid blinking and head nodding. Levetiracetam can therefore be considered as a choice for the symptomatic therapy in neuroacanthocytosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16599284

Source DB:  PubMed          Journal:  Acta Neurol Taiwan        ISSN: 1028-768X


  6 in total

1.  Update on the Non-Huntington's Disease Choreas with Comments on the Current Nomenclature.

Authors:  Ruth H Walker
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-01-30

2.  A case of rhabdomyolysis in which levetiracetam was suspected as the cause.

Authors:  Hisanao Akiyama; Yoshiteru Haga; Naoshi Sasaki; Toshiyuki Yanagisawa; Yasuhiro Hasegawa
Journal:  Epilepsy Behav Case Rep       Date:  2014-09-16

Review 3.  Untangling the Thorns: Advances in the Neuroacanthocytosis Syndromes.

Authors:  Ruth H Walker
Journal:  J Mov Disord       Date:  2015-05-31

Review 4.  Neuroacanthocytosis in china: a review of published reports.

Authors:  Jia Liu; Benedikt Bader; Adrian Danek
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2014-10-31

Review 5.  Management of Neuroacanthocytosis Syndromes.

Authors:  Ruth H Walker
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2015-10-19

6.  Nodding syndrome.

Authors:  Scott F Dowell; James J Sejvar; Lul Riek; Katelijn A H Vandemaele; Margaret Lamunu; Annette C Kuesel; Erich Schmutzhard; William Matuja; Sudhir Bunga; Jennifer Foltz; Thomas B Nutman; Andrea S Winkler; Anthony K Mbonye
Journal:  Emerg Infect Dis       Date:  2013       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.